TY - JOUR
TI - Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a
systematic review
AU - Dhami, Sangeeta
AU - Nurmatov, Ulugbek
AU - Roberts, Graham
AU - Pfaar,
AU - Oliver
AU - Muraro, Antonella
AU - Ansotegui, Ignacio J.
AU - Calderon,
AU - Moises
AU - Cingi, Cemal
AU - Demoly, Pascal
AU - Durham, Stephen
AU - van
AU - Wijk, Ronald Gerth
AU - Halken, Susanne
AU - Hamelmann, Eckard and
AU - Hellings, Peter
AU - Jacobsen, Lars
AU - Knol, Edward
AU - Larenas
AU - Linnemann, Desiree
AU - Lin, Sandra
AU - Maggina, Vivian and
AU - Oude-Elberink, Hanneke
AU - Pajno, Giovanni
AU - Panwankar, Ruby and
AU - Pastorello, Elideanna
AU - Pitsios, Constantinos
AU - Rotiroti, Giuseppina
AU - and Timmermans, Frans
AU - Tsilochristou, Olympia
AU - Varga, Eva-Maria
AU - and Wilkinson, Jamie
AU - Williams, Andrew
AU - Worm, Margitta
AU - Zhang,
AU - Luo
AU - Sheikh, Aziz
JO - Clinical and Translational Allergy
PY - 2016
VL - 6
TODO - null
SP - null
PB - BMC
SN - null
TODO - 10.1186/s13601-016-0099-6
TODO - Allergy; Allergic rhinoconjunctivitis; Allergen immunotherapy; Rhinitis
TODO - Background: The European Academy of Allergy and Clinical Immunology
(EAACI) is in the process of developing the EAACI Guidelines for
Allergen Immunotherapy (AIT) for the Management of Allergic
Rhinoconjunctivitis. We seek to critically assess the effectiveness,
cost-effectiveness and safety of AIT in the management of allergic
rhinoconjunctivitis.
Methods: We will undertake a systematic review, which will involve
searching international biomedical databases for published, in progress
and unpublished evidence. Studies will be independently screened against
pre- defined eligibility criteria and critically appraised using
established instruments. Data will be descriptively and, if possible and
appropriate, quantitatively synthesised.
Conclusion: The findings from this review will be used to inform the
development of recommendations for EAACI's Guidelines on AIT.
ER -